Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Gruppo

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pediatric Radiology|March 7, 2013
Developing a pediatric endovascular thrombolysis program: a single-center experienceKamlesh Kukreja, Ralph Gruppo, Ranjit Chima, et al.
British Journal of Haematology|November 22, 2016
Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumabSatheesh Chonat, Shanmuganathan Chandrakasan, Karen Ann Kalinyak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 30, 2019
Perioperative haemostasis with full-length, PEGylated, recombinant factor VIII with extended half-life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single-arm phase III trialRalph Gruppo, Maria-Fernanda López-Fernández, Tung T Wynn, et al.
Metabolism: Clinical and Experimental|March 27, 2004
Population-specific alleles: the polymorphism (K121Q) of the human glycoprotein PC-1 gene is strongly associated with race but not with insulin resistance in black and white childrenJohn A Morrison, Ralph Gruppo, Charles J Glueck, et al.
Journal of Pediatric Hematology/Oncology|May 22, 2003
Low-dose tissue plasminogen activator thrombolysis in childrenMichael Wang, Taru Hays, Vinod Balasa, et al.
Expert Opinion on Biological Therapy|February 17, 2009
Integrated analysis of safety and efficacy of a plasma- and albumin-free recombinant factor VIII (rAHF-PFM) from six clinical studies in patients with hemophilia AAmy Shapiro, Ralph Gruppo, Ingrid Pabinger, et al.
Transfusion|May 11, 2013
Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentratesJ Michael Soucie, Paul E Monahan, Roshni Kulkarni, et al.
Transfusion|September 25, 2012
Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screeningJ Michael Soucie, Christine De Staercke, Paul E Monahan, et al.
British Journal of Haematology|August 16, 2005
Clinical and molecular variability in congenital dyserythropoietic anaemia type IHannah Tamary, Orly Dgany, Alexis Proust, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pediatric Radiology|March 7, 2013
Developing a pediatric endovascular thrombolysis program: a single-center experienceKamlesh Kukreja, Ralph Gruppo, Ranjit Chima, et al.
British Journal of Haematology|November 22, 2016
Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumabSatheesh Chonat, Shanmuganathan Chandrakasan, Karen Ann Kalinyak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 30, 2019
Perioperative haemostasis with full-length, PEGylated, recombinant factor VIII with extended half-life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single-arm phase III trialRalph Gruppo, Maria-Fernanda López-Fernández, Tung T Wynn, et al.
Metabolism: Clinical and Experimental|March 27, 2004
Population-specific alleles: the polymorphism (K121Q) of the human glycoprotein PC-1 gene is strongly associated with race but not with insulin resistance in black and white childrenJohn A Morrison, Ralph Gruppo, Charles J Glueck, et al.
Journal of Pediatric Hematology/Oncology|May 22, 2003
Low-dose tissue plasminogen activator thrombolysis in childrenMichael Wang, Taru Hays, Vinod Balasa, et al.
Expert Opinion on Biological Therapy|February 17, 2009
Integrated analysis of safety and efficacy of a plasma- and albumin-free recombinant factor VIII (rAHF-PFM) from six clinical studies in patients with hemophilia AAmy Shapiro, Ralph Gruppo, Ingrid Pabinger, et al.
Transfusion|May 11, 2013
Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentratesJ Michael Soucie, Paul E Monahan, Roshni Kulkarni, et al.
Transfusion|September 25, 2012
Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screeningJ Michael Soucie, Christine De Staercke, Paul E Monahan, et al.
British Journal of Haematology|August 16, 2005
Clinical and molecular variability in congenital dyserythropoietic anaemia type IHannah Tamary, Orly Dgany, Alexis Proust, et al.
Pageof 1